glp 1 injection FDA Approves Generic Version of Liraglutide Injection, a GLP-1 for Weight Loss Size:120 Capsules GI Support What to know about

glp 1 injection FDA Approves Generic Version of Liraglutide Injection, a GLP-1 for Weight Loss Size:120 Capsules GI Support What to know about

What to know about GLP-1 supplements for weight loss

Key Clinical Implications ✔ First evidence linking GLP-1RA use to lower obesity-associated cancer incidence specifically in obese, nondiabetic patients ✔ Potential dual benefit for weight management and cancer risk reduction ✔ Racial disparities in treatment response warrant further investigation and may impact prescribing decisions ✔ Findings support existing trends toward expanded GLP-1RA use for obesity management beyond diabetes Bottom Line This large retrospective study provides the first evidence that GLP-1 receptor agonists may be associated with reduced cancer risk in obese adults without diabetes

GI Support

Size:120 Capsules

Diabetic retinopathy Rapid improvements in glucose control have been associated with a temporary worsening of diabetic retinopathy